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Abstract: I n t r o d u c t i o n: Th e aim of the study was to evaluate the usefulness of Identifi ca-
tion of Seniors at Risk (ISAR) scale among elderly patients admitted to the department of internal 
medicine.
M a t e r i a l  a n d  m e t h o d s: Th e ISAR score was performed among patients aged >59 years aft er 
admission to the hospital ward. Data from medical history about diseases, taken medicines, falls, length 
of hospital stay and mortality were compared in patients with ISAR score of 0–1 and over 1 and in sub-
jects with and without history of falls. Regression analysis was used to detect predictors of the length of 
hospital stay or death.
R e s u l t s: Th e sample consisted of 102 subjects aged 80.9 ± 7.9 years, 45.5% of men, 34.6% had history 
of falls. Th e number of diseases was 11.3 ± 3.9 and number of medicines — 8.9 ± 3.7. Th e score of ISAR 
≥2 was found in 90.2% of patients, length of hospital stay was 10.3 ± 8.4 days, mortality rate was 9.9%. 
Patients with ISAR score <2 were younger, showed a smaller number of diseases, used less drugs and 
had less frequency of falls than those with score ≥2. Patients with history of falls had higher mean ISAR 
score, higher number of diseases and medicines than the others. Th e increased number of diseases and 
higher ISAR score signifi cantly infl uenced the length of hospital stay. None of the analyzed factors had 
any impact on mortality.
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C o n c l u s i o n: Th e score of ISAR scale together with number of diseases have a positive impact on the 
length of hospital stay.
Key words: ISAR, elderly, hospitalization, length of hospital stay.
Introduction
Population ageing is a  major global demographic trend. Th e global share of older 
persons (aged 60 years or over) increased from 9.2 per cent in 1990 to 11.7 per cent 
in 2013 and will continue to grow as a proportion of the world population, reaching 
21.1 per cent by 2050 [1]. Ageing has profound consequences on a  broad range of 
economic, political, social processes and health care. Health expenditures tend to 
grow rapidly since older persons usually require more health care in general and 
more specialized services to deal with their more complex pathologies [1]. Patients 
65 years and older represented 40 percent of hospitalized adults and nearly half of all 
healthcare dollars spent on hospitalization in 2008, but comprised less than 13 percent 
of the population in the United States [2]. With advancing age, patients tend to have 
more comorbid chronic illnesses and disability, making them more vulnerable during 
hospitalization to adverse events, including nosocomial complications and adverse 
drug reactions [3]. Moreover, bed rest, polypharmacy, tethering devices, sensory 
and sleep deprivation, and lack of proper nutrition, all contribute to functional, 
physical, and cognitive decline [3]. While most younger patients are discharged to 
home, 40  percent of patients 85 years and older are discharged to long term care 
facilities  [4]. Th ere are developed strategies that can improve outcomes for older 
patients during hospitalization. Th e best solution is the formation multidisciplinary 
hospital teams to integrate all care providers into the daily assessment and plan of care 
for older patients [5]. Assessment of risk of functional decline is crucial to plan early 
intervention in a  selected group of patients. It can also be useful for planning health 
support aft er discharge. Th e most accurate tool for this purpose is a  comprehensive 
geriatric assessment (CGA). CGA evaluates the most important problems of older 
patients, which are strongly related with further prognosis [6]. A disadvantage of 
CGA is the necessity of time and the involvement of specialized medical personnel. 
Th e alternative of CGA alone is a  two-step approach with pre-screening tools. 
Some instruments predicting loss of function are developed based on clinical or 
empirical constructions using risk factors of functional decline. One of the most 
popular prescreening scale in hospitals is Vulnerable Elders 13-Survey (VES-13) — 
self-reported 13-item instrument [7]. Higher scores of VES-13 scale were associated 
with a greater number of deaths and functional decline in long term observation [8]. 
Another simple tool is ISAR score (Identifi cation of Seniors at Risk)  [9]. ISAR was 
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developed mainly to identify seniors in an emergency department (ED) setting at 
high risk of subsequent functional decline (including institutionalization and death). 
However, there is also observation that ISAR is unsuitable as a  sole tool in clinical 
decision-making and have the poor predictive ability in older people discharged 
from acute medical units [10]. Some modifi cation of ISAR scale were validated 
in primary care and in acutely hospitalized older patients [11, 12]. However, to 
our best knowledge there is no studies, which test utility of original ISAR scale in 
assessment of elderly population admitted to the acute hospital department. Th e 
aim of that study was the estimation of ISAR scale utility in a  population of elderly 
patients admitted to the department of internal medicine for an acute worsening of 
health status. 
Study population
Th e survey was conducted among 102 patients over 59 years of age consecutively 
admitted to the hospital internal medicine ward. All patients had hospital referral 
from ED without geriatric evaluation. Patients with diagnosed dementia or delirium 
or without family members who could help to answer the questions, have been 
excluded from the study. 
Data collection
Th e ISAR score was completed by the researcher on recruitment within 48 hours 
aft er admission. ISAR consists of six self-report questions with yes/no responses [13]. 
Th e questions cover the common and most frequently observed problems in seniors 
such as functional loss (2 questions), cognitive impairment, polypharmacy, visual 
impairment and frequent hospitalizations. ISAR questions were slightly modifi ed 
for purpose of this study. We omitted the word “injury” and replaced the phrase 
“Emergency Department” with the word “Hospital” in the fi rst two questions. Th e 
total scale range is from 0 to 6, as each item is scored 1 if the patient reports having 
the problem and 0 if not. A total score ≥2/6 on the Identifi cation of Seniors At Risk 
(ISAR) tool recognizes patients at high risk of adverse health outcomes [9, 13]. 
Other baseline variables from medical documentation were included such as 
demographic data, history of falls in the past, the number of diagnosed diseases, the 
number of drugs at discharge, duration of hospitalization and death. 
Statistical analysis
Simple descriptive statistics were used to defi ne the characteristics of the study 
population. We analyzed the distribution of ISAR scores among all patients and 
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number of those with score over 1.0 point. We also performed several analyses of 
ISAR scores comparing the medical data of patients with 0 or 1 point and over 
1  point, below and over the mean score value and in three groups: I  — 0–2 scores, 
II — 3–4 scores and III — 5–6 scores. Moreover, we compared the results between the 
subjects with history of falls and those without falls in the past. Statistical analysis was 
performed with the aid of the U Mann–Whitney, Kruskal–Wallis one-way analysis of 
variance and Chi2 tests. Multivariate stepwise backward regression analysis was used 
to detect parameters which can constitute predictors of the length of hospital stay or 
death. All analyzed clinical data were used as independent variables.
Results
We studied 102 subjects aged 80.9 ± 7.9 years, 45.5% of men, 34.6% had history of 
falls. Patients suff ered from approximately 11.3 ± 3.9 diff erent diseases, and they were 
treated with 8.9 ± 3.7 medicines. Mean ISAR score was 3.6 ± 1.5. Th e mean length of 
hospital stay was 10.3 ± 8.4 days (range 1–59 days). Ten subjects (9.9%) died during 
hospitalization. Over 70% of patients (70.3%) needed help in the past, half of them 
(56.4%) presented an acute change of functioning, 65.3% complained of poor vision 
and almost 43.6% — of memory problems. Forty percent of the study population 
(40.6%) were hospitalized during last 6 months and 89.1% used 3 or more medicines. 
Th e score of ISAR ≥2 was found in almost all patients (90.2%). Th e most frequent 
scores were 3 and 4 points (60.9% patients) (Fig. 1). Patients with ISAR score <2 were 
younger, had a  smaller number of diseases, used less drugs, lower percent of them 
had a history of falls than those with score ≥2 (Table 1). 
Fig. 1. Distribution of ISAR score in the 
study elderly hospitalized patients.
Table 1. Clinical characteristics in the group of patients 
with score 0–1 point and score over 1 point.
 Score 0–1
(n = 10)
Score >1
(n = 92) p-value
Age [years] 75.9 ± 7.3 81.4 ± 7.9 0.030
History of falls [%] 0.0 39.1 NS
Mean ISAR [score]  0.9 ± 0.3  3.6 ± 1.0 <0.001
Number of diseases  8.3 ± 2.9 11.6 ± 3.9 0.020
Number of drugs  5.1 ± 1.3  9.0 ± 3.6 0.004
Days of hospitalization  8.8 ± 5.2 10.3 ± 8.9 0.810
Deceased [%] 50 3.3 NS
NS — non signifi cant
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Groups above and below the mean score diff ered by an average score and by the 
length of hospital stay (Table 2). Groups of patients with diff erent ranges of ISAR 
scores also diff ered by an average score and by the number of used drugs (Table 3). 
Table 2. Clinical characteristics in the group of patients with score higher or lower than the mean score 
of ISAR scale.
 Score <3.6(n = 40)
Score >3.6
(n = 61) p-value
Age [years] 80.2 ± 8.1 81.7 ± 7.8 0.32
History of falls [%] 28.1 40.4 NS
Mean ISAR [score]  2.4 ± 0.8  4.4 ± 0.6 <0.001
Number of diseases 10.8 ± 3.8 12.0 ± 4.0 0.16
Number of drugs  8.3 ± 3.6  9.2 ± 3.5 0.17
Days of hospitalization  8.9 ± 7.8 11.8 ± 9.5 0.03
Deceased [%] 8.8 6.7 NS
NS — non signifi cant
Table 3. Clinical characteristics in three groups of patients with diff erent range of ISAR scores.
 0–2 scores(n = 23)
3–4 scores 
(n = 62)
5–6 scores
(n = 17) p-value
Age [years] 79.1 ± 9.4 81.6 ± 8.0 80.3 ± 5.6 0.25
Mean ISAR [score]  1.5 ± 0.6  3.5 ± 0.5  5.2 ± 0.4 <0.001
Number of diseases 10.5 ± 4.0 11.2 ± 3.9 12.7 ± 4.0 0.17
Number of drugs  7.5 ± 3.9  8.6 ± 3.4 10.4 ± 3.4 0.05
Days of hospitalization  8.7 ± 5.5  9.7 ± 7.8 13.9 ± 13.3 0.16
Deceased [%] 8.8 8.8 5.9 NS
NS — non signifi cant
Th e distribution of ISAR scores was similar among fallers and non-fallers (data 
not shown). Th e percentage of patients with the score over 1,0 point were similar 
in groups with (n = 36) and without (n = 66) history of falls (100% vs. 84.8%, 
respectively). However, patients with history of falls had higher mean values of 
ISAR  scale (3.7 ± 1.1 vs. 3.1 ± 1.2, p = 0.04), higher number of diseases (12.8 ± 4.3 
vs. 10.5 ± 3.5, p = 0.007) and were treated with more drugs (10.5 ± 3.2 vs. 7.7 ± 3.4, 
p <0.001) than the others.
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In regression analysis, the length of hospital stay was signifi cantly (corrected 
R2 = 0.08; p <0.006) influenced by the increased number of diseases (β coeffi-
cient = 0.22, p = 0.03) and higher values of the ISAR score (β coefficient = 0.20, 
p <0.04). None of analyzed clinical parameters was a predictor of death among study 
subjects.
Discussion
To our knowledge, this study is the fi rst survey checking of the utility the ISAR scale 
in Polish geriatric population. Over half of patients confi rmed functional and visual 
problems. Almost half had complaints of a  memory impairment. Polypharmacy was 
detected in almost all patients and forty percent of them was hospitalized during 
last sixth months. Almost all studied patients presented 2 scores or more of ISAR 
scale. Mean ISAR score was higher among patients with falls in the past than without 
such history. Analyzed data revealed that score of ISAR scale together with number 
of diseases have a  positive impact on the length of hospital stay. However, none of 
analyzed data have an impact on mortality.
ISAR scale was developed in Canada as a  short self-report screening tool of 
elderly patients, instead of time-consuming full geriatric tests [13]. ISAR score 
allowed predicting adverse eff ects aft er ED visit such as functional decline, admission 
to a nursing home or long-term care hospital, hospitalization or death [9]. Moreover, 
it facilitated the choice of patients who need further evaluation and special medical 
care. In the next steps the ISAR scale was evaluated in diff erent countries whether it 
could predict increased risk of adverse health outcomes, but the results was not equally 
satisfactory to predict outcome [14–17]. Th e latest review of ten studies has revealed 
that it is not suitable to use the ISAR alone for identifying seniors at risk for adverse 
outcomes in the ED, because with a  cutoff  score at least 2, the ISAR was proved to 
have poor validity related to revisiting the ED and hospital readmission [10]. It has 
also shown poor to fair validity related to mortality and composite outcomes. 
Till now, there was no use of ISAR scale neither in EDs nor in hospital wards 
in Poland. In our study we tried to evaluate ISAR in population of elderly people 
admitted to hospital aft er ED visit. We choose cut-off  2 or more in our research. Th is 
cut-off  is recommended for optimal identifi cation of high risk seniors. Th e choice of 
a higher cut off  point reduces the workload of the staff , but it is missed the sensitivity 
of tool [14]. Th e majority of our patients had at least two geriatric problems according 
to the ISAR scale. 
Th e main area of evaluation of ISAR scale was ED. However, some researches 
assessed ISAR tool in a  population of elderly hospitalized patients in a  general 
internal ward of hospital. Hoogerduijn et al. [18] has compared ISAR with COMPRI 
(Complexity Prediction Instrument) and HARP (Hospital Admission Risk Profi le) 
 Identifi cation of Seniors at Risk scale as a simple tool of elderly patients’ assessment…   11
screening tools. ISAR had the best sensitivity and the best negative predictive value 
to predict functional decline than other scales [18]. Moreover, it had comparable 
predictive values for assessing functional decline with TRST (Triage Risk Screening 
Tool) but higher than VIP (Variable Indicative of Placement risk scale) [19]. None 
of the instruments was strong in predicting which patient was at risk while also 
giving a valid indication of those patients not at risk. So lately, it was developed the 
new screening tool for patients acutely admitted to an internal ward [12]. Th ose 
scale (Identifi cation of Seniors at Risk–Hospitalized Patients — ISAR-HP) also used 
a  threshold 2 to identify high risk subjects for functional decline, but recognized 
the following four problems: pre-admission need for assistance in instrumental 
activity of daily living on a regular basis, use of a walking device, need for assistance 
in travelling and no education after age 14. The ISAR-HP adequately identified 
hospitalized older people at risk for low physical and cognitive functioning, mortality, 
loneliness and, to a  lesser extent, quality of life at 3 and 12 months aft er hospital 
admission [20]. It was also supported that the amended ISAR-HP was able to 
accurately identify those at risk of functional decline following cardiac surgery [21]. 
Lately published, multicenter, prospective, observational study has shown that by 
using ISAR-HP at hospital admission, patients at low, intermediate or high risk 
for functional decline could be identifi ed, with distinct clinical characteristics and 
outcomes [22]. 
One of the great geriatric problems are falls and their impact on the outcome 
of elderly patients. In our study we compared analyzed data in the groups of fallers 
and non-fallers in the past. Th e mean values of ISAR was higher in the group with 
a  history of falls than in the others and all of them had ISAR score over 1.0 point. 
Fallers have diagnosed more diseases and used more drugs that non-fallers. Moreover, 
there was a higher percentage of patients with falls in the group with the score of 3.6 
and above than the others. No studies evaluated ISAR scale to predict risk of falls. 
However, it should be pointed out that ISAR scale contains many questions of geriatric 
problems (physical disabilities, visual impairment, memory problems, polypharmacy) 
usually evaluated among old patients with risk of falls [23, 24]. It was also confi rmed 
that underlying diseases very oft en had more important infl uence on risk of falls than 
drugs [25].
ISAR scale was found as a  good predictor of recurrent visits on ED and 
rehospitalizations [26]. We did not assess such data. However, we have revealed 
that score of ISAR scale together with number of diseases have a positive impact on 
the length of hospital stay. Th ere are no studies that evaluated association between 
ISAR scale and length of hospital stay. Nevertheless, there are researches that 
confi rmed connection between length of stay of geriatric patients and polypharmacy, 
comorbidity, dehydration, protein-energy malnutrition, urinary catheterization and 
Barthel score <45 on admission [27–29].
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ISAR scale identifi ed also patients at risk of mortality aft er discharge from ED [30]. 
Our results did not confi rmed this relationship, but the number of deaths was low 
and observation time was relatively short. 
Our study have some limitations. Study group of patients was relatively small as 
well the time of the observation. Moreover, patients were excluded from the study 
cohort if they could not be interviewed because of their clinical status or cognitive 
impairment and no informant was available. We analyzed only a  few clinical 
parameters and did not perform CGA. Data presented do not have the character 
of the analysis of reliability and validity. Additionally, the sheer ISAR scale has also 
same limitations. First, ISAR is not a diagnostic test. It should be followed by more 
detailed evaluation including social conditions. Same questions in scale could be 
inappropriate for older people living in nursing homes. Elderly patients could assess 
too optimistically their dependence for example because of shame, and member of 
family could underrate status of patients because of a fear. It is necessary to assess the 
mental status of a patient because of risk of inappropriate answer for questions. Th e 
implementation of pre-screening tool also requires planning other steps that should 
be taken. 
However, results of our survey gives an information that ISAR may be the utility 
tool in a  short screening of geriatric problems in Polish elderly patients. Evaluation 
of answers to ISAR questions made it possible to detect 3–4 geriatric problems in 
a majority of study cohort and even more in one third. Higher values of ISAR score 
were also connected with the longer time of hospitalization. Further researches should 
be performed to better evaluation or to creation of ISAR modifi cation, which will be 
more suitable as a geriatric screening tool among diff erent cohorts of Polish patients. 
Th is approach may contribute to better defi ning of treatment goals at hospital, earlier 
initiation of preventive interventions and better communication with patients and 
caregivers. 
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